9 July, 2025Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
9 July, 2025Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
24 June, 2025TISSIUM Receives FDA De Novo Authorization for COAPTIUM® CONNECT in atraumatic sutureless peripheral nerve repair
24 June, 2025Moon Surgical Expands Leadership Team to Accelerate Commercial Growth Across U.S. and Europe